http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011141113-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1a42581076af0eca45ac07d4211a042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6255860ba19ed740fac6c06b16f0c6d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12c5c0310a37459fb7cb7c2245787468
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cb5b4906b162f718c331a135d05828d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ae7719a03f6b32611962fd6183d194
publicationDate 2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011141113-A3
titleOfInvention Combination of vitamin k and nicotinamide
abstract The invention relates to a pharmaceutical composition comprising a vitamin K component and a nicotinamide component, the percentages of said vitamin K component and nicotinamide component together totalling at least 10 percent by weight, in relation to the total weight of all the physiologically active ingredients of the composition. Preferably, the composition also contains a vitamin D component. The composition is suitable for the prevention or treatment of diseases associated with an extra-osseous calcification.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104721174-B
priorityDate 2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011013138-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008317725-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102007003524-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960

Total number of triples: 36.